Robert Brucker

Company: DermBiont

Job title: Co-founder & Chief Scientific Officer

Seminars:

Interactive Working Group Roundtable Session – Meeting Rising Demand with Collective Approaches to Increase Manufacturing Capacity in Microbiome Drug Development 10:30 am

Join this interactive working session designed to bring perspectives from biopharma and CMOs to light, on today’s state of play for microbiome drug manufacture capacity. Facing capacity challenges for developers looking to up-scale, this session brings all the opportunity to discuss current strategies in the short and long-term to navigate the current manufacture landscape. Hear…Read more

day: Day Two Track B (AM)

Workshop D – Microbiome Macroeconomics: Analysing Industry Trends to Inform Microbiome Drug Development Strategy 4:00 pm

With industry trends serving as crucial guideposts for strategic decision-making in microbiome drug development, seize the opportunity in this workshop to benchmark effective practices and explore: Trend-Informed Pipeline Strategy Beyond Drug Development: Examine the latest industry trends shaping microbiome drug development, as well as across the microbiome product field, and how these inform strategic decisions…Read more

day: Workshop Track 4